Serum alanine aminotransferase (ALT) activity has been widely utilized as a key biomarker for evaluating liver inflammation and injury associated with various hepatic disorders, including hepatitis, liver malignancies, and cirrhosis. The gene discussed is GPT; the disease is inflammatory response.